Literature DB >> 34159471

Association of histological subtype with risk of recurrence in craniopharyngioma patients: a systematic review and meta-analysis.

Jie Wu1, Xiao Wu1, You Qing Yang1, Han Ding1, Le Yang1, You Yuan Bao1, Lin Zhou1, Chen Xing Yang1, Tao Hong2.   

Abstract

It is controversial whether there is a different risk of recurrence between two histological subtypes in craniopharyngioma (CP) patients. Some reported that adamantinomatous craniopharyngioma (ACP) had a higher risk of recurrence than papillary craniopharyngioma (PCP), but others reported that there is no significant difference between them. So, we conducted this systematic review and meta-analysis to determine the association between the histological subtype of CP and the rate of recurrence. A comprehensive literature search was undertaken in PubMed, EMBASE, and Web of Science for all English articles published up to November 2020. Recurrence data stratified by ACP and PCP were extracted from studies meeting inclusion criteria. A pooled analysis of the association between the histological subtype of craniopharyngioma and rates of recurrence was performed. Thirteen articles containing 974 patients were included. When stratified by two pathological subtypes, the total recurrence rate of ACP was 26.0% and PCP was 14.1%, which showed ACP associated with a higher risk of tumor recurrence than PCP (odds ratio [OR] = 2.12, 95% confidence interval [CI] = 1.36, 3.30, P = 0.00). This is the first meta-analysis focusing on histological subtypes of CP. PCP associates with a lower risk of recurrence than ACP, indicating that ACP could act as one of recurrence risk factors for CP patients. Nevertheless, large sample size and well-designed multicenter studies in which the other clinical variables are controlled to determine the histological subtype of CP as an independent recurrence risk factor are needed.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Craniopharyngioma; Histological subtype; Meta-analysis; Recurrence rate

Mesh:

Year:  2021        PMID: 34159471     DOI: 10.1007/s10143-021-01563-9

Source DB:  PubMed          Journal:  Neurosurg Rev        ISSN: 0344-5607            Impact factor:   2.800


  69 in total

1.  GRADE guidelines: 3. Rating the quality of evidence.

Authors:  Howard Balshem; Mark Helfand; Holger J Schünemann; Andrew D Oxman; Regina Kunz; Jan Brozek; Gunn E Vist; Yngve Falck-Ytter; Joerg Meerpohl; Susan Norris; Gordon H Guyatt
Journal:  J Clin Epidemiol       Date:  2011-01-05       Impact factor: 6.437

2.  Endoscopic Endonasal Transsphenoidal Surgery, A Reliable Method for Treating Primary and Recurrent/Residual Craniopharyngiomas: Nine Years of Experience.

Authors:  Ercan Bal; Kamil Öge; Mustafa Berker
Journal:  World Neurosurg       Date:  2016-07-12       Impact factor: 2.104

3.  Analysis and Long-Term Follow-Up of the Surgical Treatment of Children With Craniopharyngioma.

Authors:  Jing Cheng; Qiang Shao; Zhiyong Pan; Jin You
Journal:  J Craniofac Surg       Date:  2016-11       Impact factor: 1.046

4.  The endoscopic endonasal approach for the management of craniopharyngiomas: a series of 103 patients.

Authors:  Luigi Maria Cavallo; Giorgio Frank; Paolo Cappabianca; Domenico Solari; Diego Mazzatenta; Alessandro Villa; Matteo Zoli; Alfonso Iodice D'Enza; Felice Esposito; Ernesto Pasquini
Journal:  J Neurosurg       Date:  2014-05-02       Impact factor: 5.115

Review 5.  Histopathological and molecular predictors of growth patterns and recurrence in craniopharyngiomas: a systematic review.

Authors:  Josephine R Coury; Brittany N Davis; Christoforos P Koumas; Giovanna S Manzano; Amir R Dehdashti
Journal:  Neurosurg Rev       Date:  2018-04-17       Impact factor: 3.042

6.  [Craniopharyngiomas. Clinicopathological aspects in different age groups].

Authors:  A P Barbosa; A Varela; D Carvalho; A Cerejo; J Pereira; L Castro; E Vinha; M Monteiro; J Cruz; R Vaz; J L Medina
Journal:  Acta Med Port       Date:  2002 Mar-Apr

7.  Correlation of clinical and pathological features in surgically treated craniopharyngiomas.

Authors:  T E Adamson; O D Wiestler; P Kleihues; M G Yaşargil
Journal:  J Neurosurg       Date:  1990-07       Impact factor: 5.115

8.  A tumor-specific cellular environment at the brain invasion border of adamantinomatous craniopharyngiomas.

Authors:  Stefanie Burghaus; Annett Hölsken; Michael Buchfelder; Rudolf Fahlbusch; Beat M Riederer; Volkmar Hans; Ingmar Blümcke; Rolf Buslei
Journal:  Virchows Arch       Date:  2010-03       Impact factor: 4.064

9.  The descriptive epidemiology of craniopharyngioma.

Authors:  G R Bunin; T S Surawicz; P A Witman; S Preston-Martin; F Davis; J M Bruner
Journal:  J Neurosurg       Date:  1998-10       Impact factor: 5.115

Review 10.  A systematic review of the results of surgery and radiotherapy on tumor control for pediatric craniopharyngioma.

Authors:  Aaron J Clark; Tene A Cage; Derick Aranda; Andrew T Parsa; Peter P Sun; Kurtis I Auguste; Nalin Gupta
Journal:  Childs Nerv Syst       Date:  2012-10-23       Impact factor: 1.475

View more
  1 in total

Review 1.  Current Advances in the Management of Adult Craniopharyngiomas.

Authors:  Montserrat Lara-Velazquez; Yusuf Mehkri; Eric Panther; Jairo Hernandez; Dinesh Rao; Peter Fiester; Raafat Makary; Michael Rutenberg; Daryoush Tavanaiepour; Gazanfar Rahmathulla
Journal:  Curr Oncol       Date:  2022-03-04       Impact factor: 3.677

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.